Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3678001013 | Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
3678002018 | Dehydrocholic acid 180 mg and pancreatin 300 mg and simethicone 40 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
3678003011 | Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Is a | Dehydrocholic acid and pancreatin and simeticone only product in oral dose form | true | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Plays role | Digestant therapeutic role | true | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Is a | Dehydrocholic acid-containing product | false | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Is a | Pancreatin-containing product | false | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has active ingredient | Pancreatin | false | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has active ingredient | Dehydrocholic acid | false | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has active ingredient | Bile | false | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Is a | Simeticone-containing product | false | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has active ingredient | Simeticone | false | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has active ingredient | Simeticone | false | Inferred relationship | Some | 1 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has BoSS | Simeticone | false | Inferred relationship | Some | 1 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has presentation strength numerator value | 40 | false | Inferred relationship | Some | 1 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has active ingredient | Pancreatin | false | Inferred relationship | Some | 2 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has BoSS | Pancreatin | false | Inferred relationship | Some | 2 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has presentation strength numerator value | 300 | false | Inferred relationship | Some | 2 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has active ingredient | Dehydrocholic acid | false | Inferred relationship | Some | 3 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has BoSS | Dehydrocholic acid | false | Inferred relationship | Some | 3 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has presentation strength numerator value | 180 | false | Inferred relationship | Some | 3 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 3 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 3 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has BoSS | Pancreatin | true | Inferred relationship | Some | 1 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has presentation strength numerator value | 300 | false | Inferred relationship | Some | 1 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has BoSS | Dehydrocholic acid | true | Inferred relationship | Some | 2 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has presentation strength numerator value | 180 | false | Inferred relationship | Some | 2 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has BoSS | Simeticone | true | Inferred relationship | Some | 3 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has presentation strength numerator value | 40 | false | Inferred relationship | Some | 3 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has active ingredient | Pancreatin | false | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has active ingredient | Dehydrocholic acid | false | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has active ingredient | Simeticone | false | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has precise active ingredient | Simeticone | true | Inferred relationship | Some | 3 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Is a | Dehydrocholic acid- and pancreatin- and simethicone-containing product in oral dose form | false | Inferred relationship | Some | ||
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has precise active ingredient | Pancreatin | true | Inferred relationship | Some | 1 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Has precise active ingredient | Dehydrocholic acid | true | Inferred relationship | Some | 2 | |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Count of base of active ingredient | 3 | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets